As thousands of people await a lifesaving heart, scientists are racing to buy them more time. A promising advance from scientists in Germany offers a potential solution.

You could say that allergic disease is a systemic and inflammatory condition,” said Joks, who is both chief of the division and program director of allergy and immunology at ...

Heart disease experts are hailing the results of a clinical trial showed a strongly positive performance by a drug that ...

Genetically targeted technologies can improve heart disease treatment, but only with legislation that supports continued research and development.

The surgery is an open-heart procedure where a surgeon uses part of a blood vessel from somewhere else in your body to ...

New research from Emory University may revolutionize how clinicians understand and treat these harmful blood clots, or thrombi, a byproduct of a condition called thromboinflammation. In a ...

Coronary artery disease (CAD) continues to be a leading cause of morbidity and mortality globally. The recommendations that ...

The decision to move forward with a heart transplant is made when all other treatment options been unsuccessful.

A new drug may help protect millions of people from heart attacks and strokes by lowering a little-known risk factor in the ...

In sharp contrast to earlier studies, patients with severe triple-vessel heart disease fared equally well whether they ...

The Eli Lilly drug caused a major drop in the blood levels of Lp(a), but further research is needed to show that it will ...

You might not know you have it until you have a heart attack, stroke or other sudden event. Each year, there are approximately 605,000 heart attacks in the U.S., and 170,000 of them occur without any ...